Built Cybernetics plc (AIM:BUC)
1.850
0.00 (0.00%)
At close: Oct 31, 2025
Built Cybernetics Revenue
Built Cybernetics had revenue of 10.39M GBP in the half year ending March 31, 2025, with 136.20% growth. This brings the company's revenue in the last twelve months to 20.43M, up 6.92% year-over-year. In the fiscal year ending September 30, 2024, Built Cybernetics had annual revenue of 19.45M with 37.92% growth.
Revenue (ttm)
20.43M
Revenue Growth
+6.92%
P/S Ratio
0.32
Revenue / Employee
113.52K
Employees
180
Market Cap
6.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 19.45M | 5.35M | 37.92% |
| Sep 30, 2023 | 14.10M | 6.98M | 97.88% |
| Sep 30, 2022 | 7.13M | 822.00K | 13.04% |
| Sep 30, 2021 | 6.31M | -5.03M | -44.38% |
| Sep 30, 2020 | 11.34M | -2.38M | -17.32% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |